312 related articles for article (PubMed ID: 35669776)
1. The Dynamic Role of NK Cells in Liver Cancers: Role in HCC and HBV Associated HCC and Its Therapeutic Implications.
Sajid M; Liu L; Sun C
Front Immunol; 2022; 13():887186. PubMed ID: 35669776
[TBL] [Abstract][Full Text] [Related]
2. Natural Killer Cells and T Cells in Hepatocellular Carcinoma and Viral Hepatitis: Current Status and Perspectives for Future Immunotherapeutic Approaches.
Kalathil SG; Thanavala Y
Cells; 2021 May; 10(6):. PubMed ID: 34071188
[TBL] [Abstract][Full Text] [Related]
3. NK cell receptor imbalance and NK cell dysfunction in HBV infection and hepatocellular carcinoma.
Sun C; Sun H; Zhang C; Tian Z
Cell Mol Immunol; 2015 May; 12(3):292-302. PubMed ID: 25308752
[TBL] [Abstract][Full Text] [Related]
4. Natural killer cell dysfunction in hepatocellular carcinoma and NK cell-based immunotherapy.
Sun C; Sun HY; Xiao WH; Zhang C; Tian ZG
Acta Pharmacol Sin; 2015 Oct; 36(10):1191-9. PubMed ID: 26073325
[TBL] [Abstract][Full Text] [Related]
5. TIGIT
Yu L; Liu X; Wang X; Yan F; Wang P; Jiang Y; Du J; Yang Z
Oncoimmunology; 2021; 10(1):1942673. PubMed ID: 34249476
[TBL] [Abstract][Full Text] [Related]
6. Natural Killer Cell-Derived Interferon-Gamma Promotes Hepatocellular Carcinoma Through the Epithelial Cell Adhesion Molecule-Epithelial-to-Mesenchymal Transition Axis in Hepatitis B Virus Transgenic Mice.
Chen Y; Hao X; Sun R; Wei H; Tian Z
Hepatology; 2019 Apr; 69(4):1735-1750. PubMed ID: 30329167
[TBL] [Abstract][Full Text] [Related]
7. Development of GPC3-Specific Chimeric Antigen Receptor-Engineered Natural Killer Cells for the Treatment of Hepatocellular Carcinoma.
Yu M; Luo H; Fan M; Wu X; Shi B; Di S; Liu Y; Pan Z; Jiang H; Li Z
Mol Ther; 2018 Feb; 26(2):366-378. PubMed ID: 29339014
[TBL] [Abstract][Full Text] [Related]
8. Natural Killer Cell Responses in Hepatocellular Carcinoma: Implications for Novel Immunotherapeutic Approaches.
Mantovani S; Oliviero B; Varchetta S; Mele D; Mondelli MU
Cancers (Basel); 2020 Apr; 12(4):. PubMed ID: 32283827
[TBL] [Abstract][Full Text] [Related]
9. Multidimensional analyses reveal distinct immune microenvironment in hepatitis B virus-related hepatocellular carcinoma.
Lim CJ; Lee YH; Pan L; Lai L; Chua C; Wasser M; Lim TKH; Yeong J; Toh HC; Lee SY; Chan CY; Goh BK; Chung A; Heikenwälder M; Ng IO; Chow P; Albani S; Chew V
Gut; 2019 May; 68(5):916-927. PubMed ID: 29970455
[TBL] [Abstract][Full Text] [Related]
10. Soluble programmed death ligand-1-induced immunosuppressive effects on chimeric antigen receptor-natural killer cells targeting Glypican-3 in hepatocellular carcinoma.
Chen L; Liu S; Adah D; Sun Q; Liang Z; Ho M; Sun B
Immunology; 2023 Jun; 169(2):204-218. PubMed ID: 36640111
[TBL] [Abstract][Full Text] [Related]
11. Adaptive Subsets Limit the Anti-Tumoral NK-Cell Activity in Hepatocellular Carcinoma.
Rennert C; Tauber C; Fehrenbach P; Heim K; Bettinger D; Sogukpinar Ö; Schuch A; Zecher BF; Bengsch B; Lang SA; Bronsert P; Björkström NK; Fichtner-Feigl S; Schultheiss M; Thimme R; Hofmann M
Cells; 2021 Jun; 10(6):. PubMed ID: 34199483
[TBL] [Abstract][Full Text] [Related]
12. Liver-infiltrating CD11b
Zhang QF; Yin WW; Xia Y; Yi YY; He QF; Wang X; Ren H; Zhang DZ
Cell Mol Immunol; 2017 Oct; 14(10):819-829. PubMed ID: 27321064
[TBL] [Abstract][Full Text] [Related]
13. Natural Killer Cell Dysfunction in Hepatocellular Carcinoma: Pathogenesis and Clinical Implications.
Sung PS; Jang JW
Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30463262
[TBL] [Abstract][Full Text] [Related]
14. KIR and HLA loci are associated with hepatocellular carcinoma development in patients with hepatitis B virus infection: a case-control study.
Pan N; Jiang W; Sun H; Miao F; Qiu J; Jin H; Xu J; Shi Q; Xie W; Zhang J
PLoS One; 2011; 6(10):e25682. PubMed ID: 21998681
[TBL] [Abstract][Full Text] [Related]
15. The interactions between major immune effector cells and Hepatocellular Carcinoma: A systematic review.
Schoenberg MB; Li X; Li X; Han Y; Börner N; Koch D; Guba MO; Werner J; Bazhin AV
Int Immunopharmacol; 2021 Dec; 101(Pt A):108220. PubMed ID: 34673334
[TBL] [Abstract][Full Text] [Related]
16. CNOT7 depletion reverses natural killer cell resistance by modulating the tumor immune microenvironment of hepatocellular carcinoma.
Ren C; Ren X; Cao D; Zhao H; Zhai Z; Li H; Li Y; Fu X; He J; Zhao H
FEBS Open Bio; 2020 May; 10(5):847-860. PubMed ID: 32160402
[TBL] [Abstract][Full Text] [Related]
17. Natural Killer Cells in Liver Disease and Hepatocellular Carcinoma and the NK Cell-Based Immunotherapy.
Liu P; Chen L; Zhang H
J Immunol Res; 2018; 2018():1206737. PubMed ID: 30255103
[TBL] [Abstract][Full Text] [Related]
18. Role of Immune Cells in Patients with Hepatitis B Virus-Related Hepatocellular Carcinoma.
Cho HJ; Cheong JY
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360777
[TBL] [Abstract][Full Text] [Related]
19. STAT1 is associated with NK cell dysfunction by downregulating NKG2D transcription in chronic HBV-infected patients.
Huang X; Mo Q; Fu T; Liu Y; Diao B
Immunobiology; 2022 Nov; 227(6):152272. PubMed ID: 36122437
[TBL] [Abstract][Full Text] [Related]
20. Natural killer cells involved in tumour immune escape of hepatocellular carcinomar.
Han C; Jiang Y; Wang Z; Wang H
Int Immunopharmacol; 2019 Aug; 73():10-16. PubMed ID: 31078921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
